Challenging a Traditional Paradigm
- 1 February 2015
- journal article
- breast
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 135 (2), 262e-269e
- https://doi.org/10.1097/prs.0000000000000900
Abstract
Background: Inflammatory breast cancer is a rare but aggressive breast cancer with an overall poor prognosis. Traditionally, reconstruction has not been offered, because of poor long-term survival, the need for multimodality treatment, and complex treatment sequencing. The authors examined the safety and feasibility of free flap breast reconstruction for inflammatory breast cancer. Methods: A retrospective analysis of all patients who underwent reconstruction for inflammatory breast cancer from January of 2000 to December of 2012 was conducted. Results: Of 830 inflammatory breast cancer patients, 59 (7.1 percent; median age, 48 years; range, 27 to 65 years) underwent free flap reconstruction. All patients received chemotherapy and radiation therapy. Most patients (n = 52) underwent delayed reconstruction. Five patients with a history of prior partial mastectomy and irradiation developed inflammatory breast cancer and underwent immediate reconstruction following completion mastectomy. Two others underwent immediate chest wall and breast reconstruction following resection. Thirteen patients underwent bilateral reconstruction, and seven required a bipedicled abdominal flap for the unilateral mastectomy defect. Thirty-seven patients (62.7 percent) required revision of the reconstructed breast, and 29 (49.2 percent) had a contralateral balancing procedure to optimize symmetry. Complications occurred in 21 patients (35.6 percent), with one total flap loss (1.7 percent). The median length of follow-up was 43.9 months; 49 patients (83.1 percent) were alive without evidence of recurrent disease. Conclusions: Autologous free flap breast reconstruction can be performed safely in inflammatory breast cancer patients, with acceptable complication rates and without an increased risk for flap loss. Inflammatory breast cancer should not preclude free flap breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.Keywords
This publication has 21 references indexed in Scilit:
- Vascularized Groin Lymph Node Flap Transfer for Postmastectomy Upper Limb LymphedemaPlastic and Reconstructive Surgery, 2013
- Primary chemo-radiotherapy in the treatment of locally advanced and inflammatory breast cancerThe Breast, 2012
- Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) studyEuropean Journal of Surgical Oncology, 2011
- Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancerBreast Cancer Research and Treatment, 2011
- Optimal Timing of Delayed Free Lower Abdominal Flap Breast Reconstruction after Postmastectomy Radiation TherapyPlastic and Reconstructive Surgery, 2011
- Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear earlyCancer, 2010
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatmentAnnals of Oncology, 2010
- Surgical Management of Inflammatory Breast CancerSeminars in Oncology, 2008
- Chest Wall Reconstruction and Advanced DiseaseSeminars in Plastic Surgery, 2004
- TRAM Flap Breast Reconstruction for Patients With Advanced Breast DiseaseAnnals of Plastic Surgery, 2003